Have a personal or library account? Click to login
Association of lipoprotein levels with sleep apnea: role of autonomic dysfunction Cover

Association of lipoprotein levels with sleep apnea: role of autonomic dysfunction

Open Access
|Jan 2021

References

  1. Adedayo AM, Olafiranye O, Smith D, Hill A, Zizi F, Brown C, Jean-Louis G. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath 18, 13–18, 2014.10.1007/s11325-012-0760-9480536622903801
  2. Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AG. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16, 644–647, 2000.10.1034/j.1399-3003.2000.16d13.x11106206
  3. Celovska D, Kruzliak P, Rodrigo L, Gonsorcik J, Sabaka P, Gaspar P, Delev D, Petrovic D, Dukat A, Gaspar L. Effect of low dose Atorvastatin therapy on baroreflex sensitivity in hypertensives. High Blood Press Cardiovasc Prev 23, 133–140, 2016.10.1007/s40292-016-0154-327160718
  4. Cortelli P, Lombardi C, Montagna P, Parati G. Baroreflex modulation during sleep and in obstructive sleep apnea syndrome. Auton Neurosci 169, 7–11, 2012.10.1016/j.autneu.2012.02.00522465134
  5. Dallinga-Thie GM, Franssen R, Mooij HL, Visser ME, Hassing HC, Peelman F, Kastelein JJ, Peterfy M, Nieuwdorp M. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis 211, 1–8, 2010.10.1016/j.atherosclerosis.2009.12.027392477420117784
  6. Drager LF, Jun J, Polotsky VY. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 17, 161–165, 2010.10.1097/MED.0b013e3283373624290475120125003
  7. Drager LF, Polotsky VY. Lipid metabolism: a new frontier in sleep apnea research. Am J Respir Crit Care Med 184, 288–290, 2011.10.1164/rccm.201105-0837ED317553921804119
  8. Ginter E, Simko V. New data on harmful effects of trans-fatty acids. Bratisl Lek Listy 117, 251–253, 2016.10.4149/BLL_2016_04827215959
  9. Chapleau MW. Baroreceptor Reflexes. Sympatho-vagal imbalance in hypertension. In: Primer on the autonomic nervous system (Ed. D Robertson), pp. 161–165, Elsevier, San Diego, 2012.10.1016/B978-0-12-386525-0.00033-0
  10. Chou YT, Chuang LP, Li HY, Fu JY, Lin SW, Yang CT, Chen NH. Hyperlipidaemia in patients with sleep-related breathing disorders: prevalence & risk factors. Ind J Med Res 131, 121, 2010.
  11. Iber CAIS, Chesson A, Quan SF. The AASM Manual for the scoring of sleep and associated events: Rules, terminology and technical specification. American Academy of Sleep Medicine, Westchester, 2007.
  12. Indumathy J, Pal GK, Pal P, Ananthanarayanan PH, Parija SC, Balachander J, Dutta TK. Decreased baroreflex sensitivity is linked to sympathovagal imbalance, body fat mass and altered cardiometabolic profile in pre-obesity and obesity. Metabolism 64, 1704–1714, 2015.10.1016/j.metabol.2015.09.00926454717
  13. Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol 293, 1–4, 2007.10.1152/ajpgi.00554.2006
  14. Jun J, Polotsky VY. Sleep disordered breathing and metabolic effects: evidence from animal models. Sleep Med Clin 2, 263–277, 2007.10.1016/j.jsmc.2007.03.009
  15. Jun J, Polotsky VY. Metabolic consequences of sleep-disordered breathing. Ilar J 50, 289–306, 2009.10.1093/ilar.50.3.289
  16. Kwiterovich PO, Jr. Lipoprotein heterogeneity: diagnostic and therapeutic implications. Am J Cardiol 90, 1–10, 2002.10.1016/S0002-9149(02)02796-0
  17. La Rovere MT, Pinna GD. Beneficial effects of physical activity on baroreflex control in the elderly. Ann Noninvasive Electrocardiol 19, 303–310, 2014.10.1111/anec.12170693239224844457
  18. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48, 275–297, 2009.10.1016/j.plipres.2009.05.00119464318
  19. Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, Smith PL, Marino RL, Rodriguez A, Hubbard WC, O’Donnell CP, Polotsky VY. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97, 698–706, 2005.10.1161/01.RES.0000183879.60089.a916123334
  20. Li J, Savransky V, Nanayakkara A, Smith PL, O’Donnell CP, Polotsky VY. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Phisiol (1985) 102, 557–563, 2007a.10.1152/japplphysiol.01081.200617082365
  21. Li J, Nanayakkara A, Jun J, Savransky V, Polotsky VY. Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia. Physiol Genomics 31, 273–280, 2007b.10.1152/physiolgenomics.00082.200717666524
  22. Lira FS, Rosa Neto JC, Antunes BM, Fernandes RA. The relationship between inflammation, dyslipidemia and physical exercise: from the epidemiological to molecular approach. Curr Diabetes Rev 10, 391–396, 2014.10.2174/157339981066614112221013525418583
  23. Nadeem R, Singh M, Nida M, Waheed I, Khan A, Ahmed S, Naseem J, Champeau D. Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 10, 475–489, 2014.10.5664/jcsm.3690404636024910548
  24. Narkiewicz K, van de Borne PJH, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98, 772–776, 1998.10.1161/01.CIR.98.8.7729727547
  25. Nasr N, Pavy-Le Traon A, Larrue V. Baroreflex sensitivity is impaired in bilateral carotid atherosclerosis. Stroke 36, 1891–1895, 2005.10.1161/01.STR.0000177890.30065.cb16100025
  26. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, Quan SF. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154, 50–59, 2001.10.1093/aje/154.1.5011434366
  27. Oravec S, Dukat A, Gavornik P, Caprnda M, Kucera M, Ocadlik I. Contribution of the atherogenic lipoprotein profile to the development of arterial hypertension. Bratisl Lek Listy 112, 4–7, 2011.
  28. Patterson D, Dick JB, Struthers AD. Intensive statin treatment improves baroreflex sensitivity: another cardioprotective mechanism for statins? Heart 88, 415–416, 2002.10.1136/heart.88.4.415176736312231607
  29. Roche F, Sforza E, Pichot V, Maudoux D, Garcin A, Celle S, Picard-Kossovsky M, Gaspoz JM, Barthelemy JC. Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 10, 882–886, 2009.10.1016/j.sleep.2008.07.01719200781
  30. Ryan S, Ward S, Heneghan C, McNicholas WT. Predictors of decreased spontaneous baroreflex sensitivity in obstructive sleep apnea syndrome. Chest 131, 1100–1107, 2007.10.1378/chest.06-216517426215
  31. Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A, Polotsky VY. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175, 1290–1297, 2007.10.1164/rccm.200612-1771OC217609017332479
  32. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162, 566–570, 2000.10.1164/ajrccm.162.2.990809110934088
  33. Siarnik P, Carnicka Z, Krizova L, Wagnerova H, Sutovsky S, Klobucnikova K, Kollar B, Turcani P, Sykora M. Predictors of impaired endothelial function in obstructive sleep apnea syndrome. Neuro Endocrinol Lett 35, 142–148, 2014.
  34. Sykora M, Diedler J, Rupp A, Turcani P, Steiner T. Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement, but not with carotid atherosclerosis. Stroke 40, 737–742, 2009.10.1161/STROKEAHA.108.51996719118245
  35. Xu H, Yi H, Guan J, Yin S. Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials. Atherosclerosis. 234, 446–453, 2014.10.1016/j.atherosclerosis.2014.03.03424769714
  36. Zhang W, Sun Y, Li T, Zhang G, Wang Y, Sun H. The effect of obstructive sleep apnea-hypopnea syndrome on acute myocardial infarction. Bratisl Lek Listy 113, 565–568, 2012.10.4149/BLL_2012_127
DOI: https://doi.org/10.2478/enr-2021-0004 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 22 - 29
Published on: Jan 29, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Pavel Siarnik, Adela Penesova, Zofia Radikova, Alzbeta Hluchanova, Oto Hanus, Katarina Klobucnikova, Peter Turcani, Branislav Kollar, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.